Death
Irreversible cessation of all bodily functions, manifested by absence of spontaneous breathing and total loss of cardiovascular and cerebral functions.
Subtype terms (11)
More specific conditions that are subtypes of Death in the MeSH hierarchy.
- Asphyxia
13 drugs (10 approved, 3 experimental)
- Body Remains
- Brain Death
19 drugs (16 approved, 3 experimental)
- Cadaver
- Death, Sudden
5 drugs (3 approved, 2 experimental)
- Drowning
1 drug experimental
- Embryo Loss
2 drugs approved
- Fetal Death
4 drugs approved
- Infant Death
1 drug approved
- Parental Death
- Perinatal Death
15 drugs (11 approved, 4 experimental)
Drugs by status
Phase 4 trials (5)
Phase 2 trials (3)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (32)
- AstraZeneca
- Gynuity Health Projects
- Pronova BioPharma
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- Boston University
- Duke University
- Federal University of Health Science of Porto Alegre
- Indian Council of Medical Research
- Indiana University
- RTI International
- Stiftung Institut fuer Herzinfarktforschung
- Thomas Jefferson University
- University of Virginia
- Aga Khan University
- Aspirus Heart and Vascular Institute-Research and Education
- Columbia University
- University of Colorado, Denver
- University of Kinshasa
- International Center for Diarrheal Disease Research
- University of North Carolina at Chapel Hill
- University of Alabama, Birmingham
- Lata Medical Research Foundation, Nagpur, India
- TIMI Study Group, Boston, MA
- Society for Applied Studies, New Delhi
- Bill and Melinda Gates Foundation
- KLE University
- University Teaching Hospital, Lusaka, Zambia
- Moi Univeristy
- Trommsdorff GmbH & Co. KG
- +2 more
Organization Involved with Phase 2 Indications (12)
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (12)